SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
PTHS

Pelthos Therapeutics Inc. (New York Stock Exchange Arca:PTHS)

US · Delayed Price · Currency is USD
Healthcare · Biotechnology
16.19-0.81 (-4.76%)
 
Market cap
$62.0M
Health Score
Analyst consensus
Listed since
Feb 16, 2024
Insider Score
––Not scored
PTHS Insider Score

Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.

PTHS Stock Insider Trading Activity

PTHS stock’s insider trading shows 2 purchases for an estimated $999.98K and 12 sales on the open market for an estimated $148.87K by company insiders over the last 6 months.

Not enough price history.

Insider Trading Activity (Form 4 Filings)

An insider trade occurs when an individual that has non-public information about a company buys or sells shares of that company’s stock. Examples of insiders include a company’s executive officers (CEO, CFO, COO), its board of directors, and its major shareholders. Insiders are required to submit their trading activity to the SEC through Form 4 filings.

Scored window · last 90 days0 qualifying buys0 insiders$0 bought— these are the numbers in the rankings table; the full history below shows every filing (buys, sells and older activity).
InsiderActionSharesAvg CostTotalΔ HoldingsHeld AfterDateGradeForm 4
Pauls Matthew
Director
Sell786$21.00$16.51K 5.5%13,578Oct 2, 2026— Form 4
Greenleaf Peter
Director
Sell797$21.17$16.87K 3.3%23,087Oct 2, 2026— Form 4
Friedberg Ezra M
Director
Sell558$20.72$11.56K 0.7%80,484Oct 2, 2026— Form 4
Pauls Matthew
Director
Sell692$26.00$17.99K 4.6%14,458Jul 2, 2026— Form 4
Pauls Matthew
Director
Sell94$27.36$2.57K 0.7%14,364Jul 2, 2026— Form 4
Greenleaf Peter
Director
Sell85$27.27$2.32K 0.4%23,884Jul 2, 2026— Form 4
Greenleaf Peter
Director
Sell712$26.00$18.51K 2.9%23,969Jul 2, 2026— Form 4
Friedberg Ezra M
Director
Sell534$26.03$13.90K 0.7%81,066Jul 2, 2026— Form 4
Friedberg Ezra M
Director
Sell24$27.33$655.81 0.0%81,042Jul 2, 2026— Form 4
Friedberg Ezra M
Director
Sell224$27.12$6.08K 0.3%81,659Jun 15, 2026— Form 4
Friedberg Ezra M
Director
Sell59$27.94$1.65K 0.1%81,600Jun 15, 2026— Form 4
Davis Todd C
Director
Buy35,445$27.80$985.53K 88.9%75,331Jun 11, 2026AFirst BuyDilution Form 4
Davis Todd C
Director
Buy503$28.73$14.45K 0.7%75,834Jun 11, 2026CFirst BuyDilution Form 4
Francis Knuettel II
CFO
Sell1,500$26.84$40.26K 11.7%11,316May 22, 2026— Form 4
Friedberg Ezra M
Director
Tax withheld144$27.01$3.89K 0.2%81,883May 14, 2026— Form 4
Greenleaf Peter
Director
Sell420$20.52$8.62K 1.6%25,058Apr 2, 2026— Form 4
Malamut Richard
Director
Sell310$20.51$6.36K 1.1%27,702Apr 2, 2026— Form 4
Malamut Richard
Director
Sell280$21.36$5.98K 1.0%27,422Apr 2, 2026— Form 4
Friedberg Ezra M
Director
Sell293$20.51$6.01K 0.4%82,292Apr 2, 2026— Form 4
Friedberg Ezra M
Director
Sell265$21.36$5.66K 0.3%82,027Apr 2, 2026— Form 4
Pauls Matthew
Director
Sell415$20.52$8.51K 2.6%15,521Apr 2, 2026— Form 4
Pauls Matthew
Director
Sell371$21.36$7.93K 2.4%15,150Apr 2, 2026— Form 4
Greenleaf Peter
Director
Sell377$21.36$8.05K 1.5%24,681Apr 2, 2026— Form 4
Einhorn Andrew J.
Director
Award12,000—— New12,000Dec 23, 2025— Form 4
Pauls Matthew
Director
Gift9,542—— 89.9%1,074Dec 10, 2025— Form 4
Friedberg Ezra M
Director
Sell2,000$28.00$56.01K 6.3%30,000Nov 25, 2025— Form 4
What these mean— the action is the SEC’s own Form 4 transaction code. Only a buy or a sell is an open-market trade; the rest are transfers, awards and exercises, which is why they carry no price.
  • Buy (P) — Open-market or private purchase
  • Sell (S) — Open-market or private sale
  • Award (A) — Grant or award from the company, not a purchase
  • Tax withheld (F) — Shares withheld to pay tax or an exercise price
  • Gift (G) — Bona fide gift
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.